Literature DB >> 35386071

Bmal1- and Per2-mediated regulation of the osteogenic differentiation and proliferation of mouse bone marrow mesenchymal stem cells by modulating the Wnt/β-catenin pathway.

Jiawen Zheng1,2, Lanxin Zhang1,2, Zhen Tan3,4, Qing Zhao5,6, Xiaoyu Wei1,2, Yuqing Yang1,2, Rong Li1,2.   

Abstract

BACKGROUND: Bmal1 and Per2 are the core components of the circadian clock genes (CCGs). Bmal1-/- mice exhibit premature aging, as indicated by hypotrichosis and osteoporosis, with a loss of proliferation ability. The same occurs in Per2-/- mice, albeit to a less severe degree. However, whether the effects of Bmal1 and Per2 on proliferation and osteogenic differentiation are synergistic or antagonistic remains unclear. Thus, our study aimed to explore the effects and specific mechanism. METHODS AND
RESULTS: Lentiviral and adenoviral vectors were constructed to silence or overexpress Bmal1 or Per2 and MTT, flow cytometry, RT-qPCR, WB, immunohistochemistry, alizarin red staining and ChIP-Seq analyses were applied to identify the possible mechanism. The successful knockdown and overexpression of Bmal1/Per2 were detected by fluorescence microcopy. Flow cytometry found out that Bmal1 or Per2 knockdown resulted in G1-phase cell cycle arrest. RT-qPCR showed the different expression levels of Wnt-3a, c-myc1 and axin2 in the Wnt/β-catenin signaling pathway as well as the gene expression change of Rorα and Rev-erbα. Meanwhile, related proteins such as β-catenin, TCF-1, and P-GSK-3β were detected. ALP activity and the amount of mineral nodules were compared. ChIP-Seq results showed the possible mechanism.
CONCLUSIONS: Bmal1 and Per2, as primary canonical clock genes, showed synergistic effects on the proliferation and differentiation of BMSCs. They would inhibit the Wnt/β-catenin signaling pathway by downregulating Rorα expression or upregulating Rev-erbα expression, both of which were also key elements of CCGs. And this may be the mechanism by which they negatively regulate the osteogenic differentiation of BMSCs. Bmal1 and Per2 show synergistic effects in the proliferation of BMSCs. In addition, they play a synergistic role in negatively regulating the osteogenic differentiation ability of BMSCs. Bmal1 and Per2 may regulate the aging of BMSCs by altering cell proliferation and osteogenic differentiation through Rorα and Rev-erbα to affect Wnt/β-catenin pathway.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Aging; BMSCs; CCGs; Osteogenic differentiation; Proliferation

Mesh:

Substances:

Year:  2022        PMID: 35386071     DOI: 10.1007/s11033-022-07292-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  44 in total

Review 1.  The aging clock: circadian rhythms and later life.

Authors:  Suzanne Hood; Shimon Amir
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

2.  Over-expression of circadian clock gene Bmal1 affects proliferation and the canonical Wnt pathway in NIH-3T3 cells.

Authors:  Fuwei Lin; Yijia Chen; Xiaolong Li; Qing Zhao; Zhen Tan
Journal:  Cell Biochem Funct       Date:  2012-09-07       Impact factor: 3.685

3.  Circadian oscillation of TNF-α gene expression regulated by clock gene, BMAL1 and CLOCK1, in the Japanese medaka (Oryzias latipes).

Authors:  Teika Onoue; Goshi Nishi; Jun-Ichi Hikima; Masahiro Sakai; Tomoya Kono
Journal:  Int Immunopharmacol       Date:  2019-03-07       Impact factor: 4.932

4.  Icariin recovers the osteogenic differentiation and bone formation of bone marrow stromal cells from a rat model of estrogen deficiency-induced osteoporosis.

Authors:  Zhiqiang Luo; Minglu Liu; Likun Sun; Feilong Rui
Journal:  Mol Med Rep       Date:  2015-02-17       Impact factor: 2.952

5.  Proof of Concept on Functionality Improvement of Mesenchymal Stem-Cells, in Postmenopausal Osteoporotic Women Treated with Teriparatide (PTH1-34), After Suffering Atypical Fractures.

Authors:  Antonio Casado-Díaz; Gabriel Dorado; Mercè Giner; María José Montoya; Cristina Navarro-Valverde; Adolfo Díez-Pérez; José Manuel Quesada-Gómez
Journal:  Calcif Tissue Int       Date:  2019-02-06       Impact factor: 4.333

6.  Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock.

Authors:  Roman V Kondratov; Anna A Kondratova; Victoria Y Gorbacheva; Olena V Vykhovanets; Marina P Antoch
Journal:  Genes Dev       Date:  2006-07-15       Impact factor: 11.361

7.  Bromocriptine improves glucose tolerance independent of circadian timing, prolactin, or the melanocortin-4 receptor.

Authors:  Sarah N Framnes-DeBoer; Ellen Bakke; Suma Yalamanchili; Hannah Peterson; Darleen A Sandoval; Randy J Seeley; Deanna M Arble
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-12-03       Impact factor: 4.310

8.  Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice.

Authors:  Erin L McDearmon; Kush N Patel; Caroline H Ko; Jacqueline A Walisser; Andrew C Schook; Jason L Chong; Lisa D Wilsbacher; Eun J Song; Hee-Kyung Hong; Christopher A Bradfield; Joseph S Takahashi
Journal:  Science       Date:  2006-11-24       Impact factor: 47.728

9.  3D Printed Zn-doped Mesoporous Silica-incorporated Poly-L-lactic Acid Scaffolds for Bone Repair.

Authors:  Guowen Qian; Lemin Zhang; Guoyong Wang; Zhengyu Zhao; Shuping Peng; Cijun Shuai
Journal:  Int J Bioprint       Date:  2021-03-10
View more
  2 in total

1.  Effect of Rhizoma Drynariae on differential gene expression in ovariectomized rats with osteoporosis based on transcriptome sequencing.

Authors:  Hui Su; Haipeng Xue; Shang Gao; Binghan Yan; Ruochong Wang; Guoqing Tan; Zhanwang Xu; Lingfeng Zeng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-02       Impact factor: 6.055

2.  Meta-Analysis of Mechanism of Influence of CRY2 on the Differentiation of Mouse Osteoblast through the Regulation of Wnt/Β-Catenin Signaling Pathway.

Authors:  Chao Ma; Chaojian Yang; Tong Xie; Wenjuan Dai; Jun Ma
Journal:  Biomed Res Int       Date:  2022-08-21       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.